ADM reported third-quarter 2026 adjusted EPS of $1.77 and total segment operating profit of $1.4 billion, driven by favorable biofuels margins. It raised full-year 2026 adjusted EPS guidance to $5.50 to $5.80 from $5.15 to $5.60 and resumed share repurchases.
ADM · Archer-Daniels-Midland Co
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Archer-Daniels-Midland Company reported earnings before income taxes of $997 million for the three months ended September 30, 2026, driven by improved operational execution, a constructive pricing environment and policy incentives.
Archer-Daniels-Midland Company reported third-quarter GAAP EPS of $1.70 and adjusted EPS of $1.77, raised full-year 2026 adjusted EPS guidance to approximately $5.50 to $5.80, and projected capital expenditures of $1.2 to $1.3 billion.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 4, 2026TL;DR. ADM reported strong Q2 2026 results with adjusted EPS of $1.84 (+98% YoY) and total segment operating profit of $1.45B (+75% YoY), driven by a constructive biofuels environment and Nutrition momentum, and raised full-year 2026 adjusted EPS guidance to $5.15–$5.60 from $4.15–$4.70.
- + Raised full-year 2026 adjusted EPS guidance to $5.15–$5.60 from $4.15–$4.70
- + Total segment operating profit rose 75% YoY to $1.45B, with Crushing up $330M and Ag Services up 159%
- + Nutrition segment operating profit grew 51% YoY, led by Flavors and Decatur East progress
- + Raised expected full-year 2026 net benefit from 45Z tax credit to ~$250M from ~$150M
- + Global oilseed crush volumes rose ~5% YoY, with record U.S. and Brazilian soybean meal exports
- + Cash flow from operations before working capital of $1.8B YTD; evaluating return to opportunistic share repurchases
- − Equity earnings from Wilmar fell 22% YoY to $60M
- − Nutrition revenues declined 5% YoY to $1.9B, with Human Nutrition down 4% and Animal Nutrition down 6%
- − Refined Products & Other segment operating profit declined 3% YoY on negative mark-to-market impacts and South American oversupply
- − Continued pressure in liquid sweetener volumes and margins in Carbohydrate Solutions
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $1.47B | Quarter ended June 30, 2026 | — |
| Adjusted EPS non-GAAP | $1.84 | 2Q26 | — |
| Adjusted net earnings non-GAAP | 895M | 2Q26 | — |
| Ag Services & Oilseeds segment operating profit | 867M | 2Q26 | +128.8% |
|
|
|||
| Animal Nutrition non-GAAP | 33M | 2Q 2026 | — |
| Carbohydrate Solutions segment operating profit | 411M | 2Q26 | — |
| Cash flows from operations before working capital non-GAAP | 1.8B | Year-to-date 2026 | — |
| Corn processed volume | 4.74M | Quarter ended June 30, 2026 | — |
| EBITDA non-GAAP | 1.49B | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net Earnings 908M
+4M Net gain (loss) attributable to non-controlling interests
+176M Income tax expense
+107M Interest expense
+292M Depreciation and amortization
= EBITDA 1.49B
|
|||
| Human Nutrition non-GAAP | 139M | 2Q 2026 | — |
| Nutrition segment operating profit | 172M | 2Q26 | — |
| Oilseeds processed volume | 9.48M | Quarter ended June 30, 2026 | — |
| Segment Operating Profit (Carbohydrate Solutions) non-GAAP | 411M | 2Q 2026 | +22.0% |
|
|
|||
| Segment Operating Profit (Nutrition) non-GAAP | 172M | 2Q 2026 | +50.9% |
|
|
|||
| Starches and Sweeteners non-GAAP | 326M | 2Q 2026 | — |
| Total Carbohydrate Solutions | 411M | the three months ended June 30, 2026 filing | — |
| Total Nutrition | 172M | the three months ended June 30, 2026 filing | — |
| Total Segment Operating Profit non-GAAP | $2.21B | Six months ended June 30, 2026 | — |
|
|
|||
| Vantage Corn Processors non-GAAP | 85M | 2Q 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Farm Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ADM
this stock
Archer-Daniels-Midland Co
|
$34.69B | +26.8% | -6.2% | 14.2 | 2.6% |
|
TSN
Tyson Foods, Inc.
|
$20.69B | +0.3% | +2.1% | 36.3 | 3.1% |
|
BG
Bunge Global SA
|
$19.53B | +14.1% | +32.4% | 17.1 | 4.0% |
|
CALM
Cal-Maine Foods Inc
|
$3.10B | -16.5% | -31.7% | — | 13.8% |
|
DOLE
Dole plc
|
$1.34B | -4.5% | +8.2% | 14.6 | 4.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 3, 2026
- This year
- 21
Archer-Daniels-Midland Company reported earnings before income taxes of $997 million for the three months ended September 30, 2026, driven by improved operational execution, a constructive pricing environment and policy incentives.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ADM | +4.2% | -11.8% | -6.6% | -5.2% | +26.8% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +1.6% | -10.6% | -7.1% | -5.0% | +16.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.